EU Agency Backs Zeltia Drug for Ovarian Cancer

Shares in Spain’s Zeltia soared after advisors to European regulators recommended the loss-making pharmaceutical firm’s Yondelis drug for use in the treatment of ovarian cancer.
Forbes